Correlation Between Oryzon Genomics and Laboratorios Farmaceuticos
Can any of the company-specific risk be diversified away by investing in both Oryzon Genomics and Laboratorios Farmaceuticos at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oryzon Genomics and Laboratorios Farmaceuticos into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oryzon Genomics SA and Laboratorios Farmaceuticos ROVI, you can compare the effects of market volatilities on Oryzon Genomics and Laboratorios Farmaceuticos and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oryzon Genomics with a short position of Laboratorios Farmaceuticos. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oryzon Genomics and Laboratorios Farmaceuticos.
Diversification Opportunities for Oryzon Genomics and Laboratorios Farmaceuticos
-0.77 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Oryzon and Laboratorios is -0.77. Overlapping area represents the amount of risk that can be diversified away by holding Oryzon Genomics SA and Laboratorios Farmaceuticos ROV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Laboratorios Farmaceuticos and Oryzon Genomics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oryzon Genomics SA are associated (or correlated) with Laboratorios Farmaceuticos. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Laboratorios Farmaceuticos has no effect on the direction of Oryzon Genomics i.e., Oryzon Genomics and Laboratorios Farmaceuticos go up and down completely randomly.
Pair Corralation between Oryzon Genomics and Laboratorios Farmaceuticos
Assuming the 90 days trading horizon Oryzon Genomics SA is expected to generate 1.79 times more return on investment than Laboratorios Farmaceuticos. However, Oryzon Genomics is 1.79 times more volatile than Laboratorios Farmaceuticos ROVI. It trades about 0.04 of its potential returns per unit of risk. Laboratorios Farmaceuticos ROVI is currently generating about 0.0 per unit of risk. If you would invest 209.00 in Oryzon Genomics SA on January 25, 2025 and sell it today you would earn a total of 62.00 from holding Oryzon Genomics SA or generate 29.67% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Oryzon Genomics SA vs. Laboratorios Farmaceuticos ROV
Performance |
Timeline |
Oryzon Genomics SA |
Laboratorios Farmaceuticos |
Oryzon Genomics and Laboratorios Farmaceuticos Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Oryzon Genomics and Laboratorios Farmaceuticos
The main advantage of trading using opposite Oryzon Genomics and Laboratorios Farmaceuticos positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oryzon Genomics position performs unexpectedly, Laboratorios Farmaceuticos can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Laboratorios Farmaceuticos will offset losses from the drop in Laboratorios Farmaceuticos' long position.Oryzon Genomics vs. Grifols SA | Oryzon Genomics vs. Acerinox | Oryzon Genomics vs. Laboratorios Farmaceuticos ROVI | Oryzon Genomics vs. ENCE Energa y |
Laboratorios Farmaceuticos vs. Grifols SA | Laboratorios Farmaceuticos vs. Acerinox | Laboratorios Farmaceuticos vs. ENCE Energa y | Laboratorios Farmaceuticos vs. CIE Automotive SA |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |